evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract
6219,GENE_SUMMARY,,"ANKRD11, a chromatin regulator, is inactivated by mutation or deletion in various cancers.",,2017-10-23,,29123,ANKRD11,ankyrin repeat domain 11,False,ENST00000301030,NM_013275.5,ANCO1,LZ16,T13,ANCO-1,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6220,GENE_BACKGROUND,,"The ANKRD11 (Ankyrin repeat domain 11) is an ankyrin repeat domain protein that binds and suppresses the function of the p160 coactivator family (PMID: 15184363), thereby inhibiting ligand-dependent transcriptional activation. ANKRD11 has also been identified as a coactivator of the p53 tumor suppressor (PMID: 18840648), thereby influencing many pathways relevant to cancer, including transcriptional initiation, cell cycle regulation, ion transport and Notch signaling. Heterozygous mutations in ANKRD11 have been reported to cause KBG syndrome, a rare disorder characterized by intellectual disability, behavioral problems, and macrodontia (PMID: 21782149 ). ANKRD11 has been identified as a putative tumor suppressor gene in breast cancer (PMID: 22538187).",,2017-09-29,,29123,ANKRD11,ankyrin repeat domain 11,False,ENST00000301030,NM_013275.5,ANCO1,LZ16,T13,ANCO-1,False,15184363,Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators.,The Journal of biological chemistry,2018-08-06T20:04:00,279,32,33799-805,Zhang A et al,,,2018-08-06T08:05:00,,22538187,Specific-site methylation of tumour suppressor ANKRD11 in breast cancer.,"European journal of cancer (Oxford, England : 1990)",2018-11-01T20:12:00,48,17,3300-9,Lim SP et al,doi: 10.1016/j.ejca.2012.03.023,,0001-11-01,,21782149,"Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia.",American journal of human genetics,2018-08-12T20:11:00,89,2,289-94,Sirmaci A et al,doi: 10.1016/j.ajhg.2011.06.007,,0001-08-12,,18840648,Identification of ANKRD11 as a p53 coactivator.,Journal of cell science,2018-11-01T20:08:00,121,Pt 21,3541-52,Neilsen PM et al,doi: 10.1242/jcs.026351,,0001-11-01,
